Biologics Market in Brazil

Regulations and Patent Expirations Challenge Brazilian Laboratories

USD 3,950.00

* Required Fields

USD 3,950.00


Be the first to review this product

This research service considers the biologics market in Brazil. It covers the market’s move toward greater regulation and outlines the impact of specific patent expirations. An analysis of monoclonal antibodies, blood factors, insulin, filgrastim, interferon, growth hormones, and erythropoietin is provided. This service also highlights key market drivers and restraints in addition to breaking down the current and forecasted competitive scenario. The base year of the study is 2010, and the forecast period is 2011 to 2017.

Table of Contents

Biologics Market in Brazil, Brazilian Biologic MarketBiologics MarketBiologics

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.